R Biopharm competitive analysis

Explore patent oppositions filed by R Biopharm against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Method For Purifying AntibodiesTHE UNITED STATES OF AMERICAApr 8, 2021
Methods And Sequences For The Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus Mrej Type V StrainsGENEOHM SCIENCES CANADADec 18, 2015
Method For High-Level Secretion And Production Of ProteinDAIICHI SANKYODec 10, 2015
Methods And Sequences For The Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus Mrej Type Viii StrainsGENEOHM SCIENCES CANADAAug 26, 2015
Methods And Sequences For The Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus Mrej Type Ix StrainsGENEOHM SCIENCES CANADAAug 26, 2015
Methods And Sequences For The Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus Mrej Type Vi StrainsGENEOHM SCIENCES CANADAAug 26, 2015

Explore R Biopharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 18, 2020Test Strip And Methods And Apparatus For Reading The Same1

Latest PTAB cases involving R Biopharm

Discover the latest PTAB cases involving R Biopharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing R Biopharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
R BIOPHARM41 - -
GENEOHM SCIENCES CANADA - 12 - -
IMMUNDIAGNOSTIK51 - -